Vitamin D3 Improves Arterial Stiffness in Dose-Response Way

Share this content:
Vitamin D<sub>3</sub> Improves Arterial Stiffness in Dose-Response Way
Vitamin D3 Improves Arterial Stiffness in Dose-Response Way

WEDNESDAY, Jan. 10, 2018 (HealthDay News) -- For overweight African-Americans with vitamin D deficiency, arterial stiffness is improved by vitamin D3 supplementation in a dose-response manner, according to a study published online Dec. 7 in PLOS ONE.

Anas Raed, M.D., from Augusta University in Georgia, and colleagues examined the dose-response effects of vitamin D3 supplementation on arterial stiffness in 70 overweight African-Americans with serum 25-hydroxyvitamin D (25[OH]D) levels ≤20 ng/mL. Participants were randomized to monthly supplementation of 18,000 IU (~600 IU/day), 60,000 IU (~2,000 IU/day), or 120,000 IU (~4,000 IU/day) of vitamin D3 or placebo for 16 weeks (17, 18, 18, and 17 participants, respectively).

The researchers observed a dose-response increase in serum 25(OH)D concentrations between the groups with vitamin D3 supplementation. For carotid-femoral pulse wave velocity (PWV), there was a significant downward linear trend, with mean changes in carotid-femoral PWV of 0.13 m/s for placebo, and 0.02, −0.11, and −0.70 m/s for the 600, 2,000, and 4,000 IU/day groups, respectively. For carotid-radial PWV, the findings were similar, with mean changes of 0.24 m/s for placebo, and 0.09, −0.57, and −0.61 m/s for the 600, 2,000, and 4,000 IU/day groups, respectively.

"Arterial stiffness was improved by vitamin D3 supplementation in a dose-response manner in overweight African-Americans with vitamin D deficiency," the authors write.

Abstract/Full Text

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters


More in Home

CDC: Birth Rate for 10- to-14-Year-Olds at Record Low in 2016

CDC: Birth Rate for 10- to-14-Year-Olds at Record ...

Reduction in birth rates for all race and Hispanic origin groups; largest decline in non-Hispanic blacks

Lonafarnib May Lower Mortality in Hutchinson-Gilford Progeria

Lonafarnib May Lower Mortality in Hutchinson-Gilford Progeria

Lower mortality seen with lonafarnib monotherapy after 2.2 years compared with no treatment

About 40 Percent of Men Report Experiencing Weight Stigma

About 40 Percent of Men Report Experiencing Weight ...

Experience of weight stigma associated with increased odds of underweight or obesity

is free, fast, and customized just for you!

Already a member?

Sign In Now »